Wednesday, March 22, 2023


T cells’ role in Alzheimer’s suggests a new treatment strategy

Drug development possibilities for brain diseases linked to tau protein.

Targeting Alzheimer’s using AI

Model tested on tens of thousands of routine brain scans spotted disease risk with 90% accuracy.

We still don’t know which factors most affect cognitive decline with age

It highlights the knowledge gap needed to reduce cognitive decline.

Study finds a correlation between neurodegeneration in obese people and Alzheimer’s disease

Obesity-related neurodegeneration mimics Alzheimer’s disease.

New blood test could detect Alzheimer’s disease 3.5 years before clinical diagnosis

The study supports the idea that components in the human blood can modulate the formation of new brain cells.

This protein could be a possible biomarker for the very early stages of Alzheimer’s

Blood-based markers may reveal Alzheimer's disease ten years before symptoms show.

FDA approved Leqembi for Alzheimer’s disease treatment

This treatment option is the latest therapy to target.

Why are women more likely to get Alzheimer’s?

A clue to the molecular cause of Alzheimer’s.

Study may explain why women are more likely to get Alzheimer’s

A modified immune protein harming brain connections is much more common in the brains of women with Alzheimer’s.

It may be possible to spot dementia signs as early as nine years before

If we can find these individuals early enough, we’ll have a better chance of seeing if the drugs are effective.

Ratio shift of protein in brain cells causes changes underlying early cognitive decline

The discovery provides a new therapeutic target to prevent the onset of neurodegenerative diseases.

Revealing hidden nanostructures in cells and tissues through a novel way

Separating densely packed molecules before imaging makes them visible for the first time.

Recent Stories